NEWS 06 March 2019 – First targeted protein degrader hits the clinic – New therapeutics that harness cellular machinery to degrade targets are entering clinical trials, led by a PROTAC anticancer candidate developed by Arvinas.


  1. I have read so many articles regarding the blogger lovers except this piece of writing is really a fastidious paragraph,
    keep it up.


  2. Nice blog! Is your theme custom made or did you download it from somewhere?
    A design like yours with a few simple adjustements would really make my blog stand out.
    Please let me know where you got your theme. Many thanks


Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s